Innovative Healthcare Experience Reports from HealthLat Make Patients Mor...(f each dollar you spend buying the repor...),Health
Navigation Links
Innovative Healthcare Experience Reports from HealthLat Make Patients More Informed
Date:10/16/2007
f each dollar you spend buying the report goes back to users who contributed information," says Johnson Chen, a HealthLat founder and former healthcare Senior in Deloitte Consulting. "And they can use the earnings to offset their own healthcare costs."
HealthLat is a pioneer and leader in collaborative consumer driven health care. The company is devoted to bringing consumers the full spectrum of information they need to make educated medical decisions as well as lowering their healthcare costs. To find out more, please visit http://www.healthlat.com.
Press Release Contact Information:
Johnson Chen
President
HealthLat LLC
(608)395-1388
This release was issued through WebWire(R). For more information visit http://www.webwire.com. SOURCE HealthLat LLC Web site: http://www.healthlat.com
'/>"/>
| Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Innovative device aids in advanced heart failure
2. Innovative footwear may prevent fall in elderly
3. Innovative yeast genome may handle Cancer Clues
4. Innovative solution to help reduce the waiting times for kidney transplants
5. Personalized Medicine and Innovative Pharmaceuticals
6. Creation of Cytomegalovirus Vaccine by an Innovative Method
7. Innovative Method for Creating a Human Cytomegalovirus Vaccine Outlined
8. Innovative treatment for Dementia
9. Innovative treatment for Skin Cancer
10. Innovative Movies Show Real-Time Immune-Cell Activity within Tumors
11. Research In A New Direction To Develop Innovative Psychotropic Drugs
Post Your Comments:
(Date:12/6/2009)... Blood clotting, or coagulation, is an important process ... is injured. Sometimes, however, clots form on the ... do not dissolve naturally, a potentially life-threatening situation ... Annual Meeting of the American Society of Hematology ... aspirin and heparin with the hope of preventing ...
(Date:12/6/2009)... says dangerous substances such as asbestos have been found in toys ... ... (PRWEB) December 6, 2009 -- As parents shop for children,s toys ... recalls due to lead paint or asbestos contamination, says a New ... emergency rooms each year due to toy-related injuries,” says Joseph W. ...
(Date:12/5/2009)... South Africa, December 5 The first Football,for ... Cape Town opened its doors,today (5 December 2009). ... Cape Premier Helen Zille, 2010 FIFA World Cup ... African Football Association,President Kirsten Nematandani and Executive Mayor ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor ... the knot, since research has shown that never-married adults have ... something wrong with those who go it alone anyway? , ... measures shows that never-married people aged 40 and up can ...
(Date:12/5/2009)... up in the most unusual places, and to do everything from growing ... ... 5, 2009 -- Who would have thought that your wine, water and ... Texas has announced a new line of turbines, for industry end users, ...
Breaking Medicine News(10 mins):Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3[1] Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages[0] Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season [0] Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha[0] Never Married, Over 40, Well-Adjusted[0] Distributor Announces New Applications for Wind Turbines
... is better than using one to stage lung cancer, and ... surgical method now most commonly used, researchers at Mayo Clinic ... the Journal of the American Medical Association. , This new ... is inserted into a patients esophagus to access lymph nodes ...
... ATRC ), a medical device company and a ... results for the fourth,quarter and full year ended December ... host a conference call at 10:00 a.m. ET on ... year 2007 results. A,live web cast of the conference ...
... Dr. Azimi offers total dental makeover to downtown Las Vegan, ... Americans, you,think extreme smile makeovers are for celebrities and the ... Las Vegas, downtown,general and cosmetic dentist, has reserved the dental ... For the first time, Dr. Azimi has agreed to donate ...
... adverse events for heart patients is in early period , , ... the first three months after heart patients stop taking the ... the first study to make this observation," said Dr. P. ... and lead author of a report in the Feb. 6 ...
... The MayaTech Corporation, a,leading provider of ... expanded its services with the establishment of ... center will study the,legal, regulatory, ethical, and ... "MayaTech recognizes that nanotechnology offers exciting,possibilities," says ...
... There is a lack of equity in health care ... in a nationwide survey and analyzed by a UT ... available online and published as an abstract in the ... certain disparities are particularly pronounced for specific racial and ...
Other Medicine News:Health News:Researchers find less invasive, highly accurate methods 2Health News:Researchers find less invasive, highly accurate methods 3Health News:Researchers find less invasive, highly accurate methods 4Health News:AtriCure Announces Web Cast and Conference Call of Fourth Quarter and Full Year 2007 Financial Results 2Health News:A Downtown Las Vegas Dental Makeover by Dr. Azimi for the Most Deserving Resident or Working Professional 2Health News:First 90 Days After Stopping Plavix Most Dangerous 2Health News:MayaTech Establishes Center to Focus on Breakthrough Technology 2Health News:National survey shows minority children experience multiple disparities in health care 2Researchers find less invasive, highly accurate methodsAtriCure Announces Web Cast and Conference Call of Fourth Quarter and Full Year 2007 Financial ResultsA Downtown Las Vegas Dental Makeover by Dr. Azimi for the Most Deserving Resident or Working ProfessionalFirst 90 Days After Stopping Plavix Most DangerousMayaTech Establishes Center to Focus on Breakthrough TechnologyNational survey shows minority children experience multiple disparities in health care
(Date:12/4/2009)... BETHESDA, Md., Dec. 4 Drs. Neal Shore and ... recurrence from the additional analysis of secondary end points ... study of FIRMAGON® (monthly degarelix for injection) or monthly ... of treatment. Prostate cancer patients who received FIRMAGON ...
(Date:12/3/2009)... 3 Guidepoint Global, LLC , a leading primary ... Tracker, a monthly longitudinal data release that monitors and projects ... ,, The Sleep Apnea Tracker captures actual patient usage ... United States from 15 different equipment providers going back to ...
(Date:12/3/2009)... (Nasdaq: PCYC ), a biopharmaceutical company focused on ... treatment of immune mediated diseases and cancer, today announced ... on, Tuesday, December 8, 2009 at 11:00am Eastern Time ... clinical data regarding its HDAC Program (PCI-24781) and its ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2CareFusion Launches 10 Pound High Performance Critical Care Ventilator in the U S 10347 1CareFusion Launches 10 Pound High Performance Critical Care Ventilator in the U S 10347 2CareFusion Launches 10 Pound High Performance Critical Care Ventilator in the U S 10347 3Many Hospitalized With Swine Flu Had Been Healthy 59397 1Many Hospitalized With Swine Flu Had Been Healthy 59397 2Many Hospitalized With Swine Flu Had Been Healthy 59397 3Scientists urge EPA to adopt systems thinking 10344 1[0] Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial[0] Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker[0] Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7
... Alnylam,Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi ... for Cancer,Research (AACR) 2007 Annual Meeting that ... ALN-VSP01, for the,treatment of liver cancer and ... program. ALN-VSP01 is an RNAi therapeutic that ...
... in Largest-Ever IVF Trial,in US, RANCHO MIRAGE, ... of,four studies evaluating Ferring Pharmaceuticals' ENDOMETRIN(R), a,novel ... phase,support (supplementation to provide support for implantation ... reproductive,technologies (ART) were presented at the 55th ...
Other Medicine Technology:Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 2Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 3Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 4Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 5Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |